NewslettersExtracellular Matrix News Extracellular Matrix Alterations and the Antifibrotic Role of Mycophenolate Mofetil in a Model of Peyronie’s Disease By Emily Salmini - September 10, 2026 0 8 Scientists evaluated ECM alterations in a rat model of Peyronie’s disease induced by transforming growth factor beta and to assess the potential antifibrotic effects of mycophenolate mofetil. [Journal of Histochemistry & Cytochemistry] Abstract